About this trial
Patients undergoing open colorectal surgery were randomly divided into two groups: Intravenous Lidocaine (IV-Lido) vs Intravenous Ketamine (IV-Keta).
For the IV-Lido group, patients received a loading dose of Lidocaine than a continuous infusion over twenty-four hours.
For the IV-Keta goup, patients received a loading dose of Ketamine than a continuous injection of Ketamine over twenty-four hours.
Plasma concentrations of Interleukin-6(IL-6) were measured preoperatively before anesthetic induction and at twenty-four hour post operatively.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 or older.
American society of anesthesiologists' (ASA) physical status of I-III.
Elective open colorectal surgery.
Patients with contraindications to lidocaine or ketamine.
Disqualifiers
Severe intraoperative complications.
Duration of surgery longer than 5 hours.
Trial design
Parallel
Treatments tested in this trial
Lidocaine IV
DrugIntravenous Lidocaine Vs intravenous Ketamine in colorectal surgery for cancer
Ketamine Injectable Solution
DrugIntravenous Lidocaine Vs intravenous Ketamine in colorectal surgery for cancer
Treatment groups
Trial outcomes
Primary outcomes
The variation of Interleukin-6 levels
The difference of Interleukine-6 (IL-6) plasma concentration between baseline values and 24 hours after surgery.
Secondary outcomes
Pain assessed by Numerical Rating Scale (NRS)
Postoperative pain was assessed by the Numerical Rating Scale (NRS)
Post-operative nausea and vomiting
Incidence of post-operative nausea and vomiting during the first 24 hours.
Bowel function.
Time to return of bowel function.
Hospital length of stay.
Hospital length of stay ( in days)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.